Cargando…
Edaravone (MCI-186) is effective as a free radical scavenger following arteriovenous sheathotomy for treatment of macular oedema associated with branch retinal vein occlusion
AIMS: To determine whether edaravone (MCI-186), a free radical scavenger, can reduce macular oedema and improve the visual acuity after arteriovenous sheathotomy in eyes with a branch retinal vein occlusion (BRVO). METHODS: Forty-seven eyes of 47 consecutive patients with a BRVO who were treated wit...
Autores principales: | Maeno, T, Tano, R, Takenaka, H, Mano, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760724/ https://www.ncbi.nlm.nih.gov/pubmed/19666924 http://dx.doi.org/10.1136/bjo.2008.154930 |
Ejemplares similares
-
Arteriovenous Sheathotomy for Persistent Macular Edema in Branch Retinal Vein Occlusion
por: Sohn, Joon Hong, et al.
Publicado: (2006) -
Long-term Visual Outcome of Arteriovenous Adventitial Sheathotomy on Branch Retinal Vein Occlusion Induced Macular Edema
por: Oh, In Kyung, et al.
Publicado: (2008) -
Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion
por: Yamane, Shin, et al.
Publicado: (2014) -
Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
por: Shefner, Jeremy, et al.
Publicado: (2019) -
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
por: Abe, Koji, et al.
Publicado: (2014)